Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Curr Opin Chem Biol. 2009 Mar 25;13(2):161–170. doi: 10.1016/j.cbpa.2009.02.030

Figure 5.

Figure 5

Inactivation of the validamycin glycosyltransferase valG and the putative cyclitol reductase valN genes resulted in mutant strains that produced new aminocyclitol products. Bioconversion of the resulting pseudodisaccharides using recombinant glycosyltransferase ValG gave their respective glycosidal products.